Health
U.K. says study supports delaying 2nd COVID-19 vaccine dose – Los Angeles Times
A study finds that the AstraZeneca-Oxford University vaccine cut coronavirus transmission by two-thirds and prevented COVID-19.
Britains health chief has hailed a new study suggesting that a single dose of the Oxford-AstraZeneca COVID-19 vaccine provides a high level of protection for 12 weeks, saying it supports the governments contentious strategy of delaying the second shot so it can protect more people quickly with a first dose.
Britains decision has been criticized as risky by other European countries, but Health Secretary Matt Hancock said Wednesday that the study backs the strategy that weve taken, and it shows the…
-
Noosa News18 hours agoFlatmates of missing teen Pheobe Bishop, 17, identified
-
Noosa News20 hours agoTully Sugar Mill celebrates 100 years of cane harvesting amid floods and cyclones
-
Noosa News17 hours agoFranz Ferdinand: Australian Tour 2025
-
General17 hours agoPostecoglou’s message touches Blues AFL coach Voss after Spurs’ Europa League win